Pablo J. Cagnoni - 31 Dec 2021 Form 5 Insider Report for Rubius Therapeutics, Inc.

Role
CEO and President, Director
Signature
/s/ Joanne M. Protano, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
5
Filing time
14 Feb 2022, 18:52:23 UTC
Previous filing
07 Jun 2021
Next filing
01 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RUBY Common Stock Gift $0 -4,000 -11% $0.000000 31,520 26 Apr 2021 Direct
transaction RUBY Common Stock Gift $0 -2,200 -7% $0.000000 29,320 16 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.